University of Geneva evaluates several ARTs against Omicron and Delta variants
- FlowFlex has a sensitivity of 91.2% against the Delta and 88.9% against the Omicron.
- Standard Q has a sensitivity of 52.9% against the Delta and 22.2% against the Omicron.
- Panbio has a sensitivity of 67.7% against the Delta and 36.1% against the Omicron.
Table 2 shows the clinical sensitivity of each ART against Delta and Omicron variants.
Figure 1 shows the analytical sensitivity of the ART against various variants
Figure 2 shows a heatmap of retrospective testing of original NP swabs from Omicron and Delta variants across 7 ARTs.
Figure 3 shows the Omicron and Delta vaccine breakthrough infections
